Source: GWASCAT ×
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Neutrophil count (procedure)
CUI: C0200633
Disease: Neutrophil count (procedure)
234 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.800 1.000 6 2011 2019
White Blood Cell Count procedure
CUI: C0023508
Disease: White Blood Cell Count procedure
1003 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.800 1.000 5 2012 2019
Monocyte count procedure
CUI: C0200637
Disease: Monocyte count procedure
296 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 2 2017 2019
Monocyte count result
CUI: C0750880
Disease: Monocyte count result
296 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 2 2017 2019
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
CUI: C1836232
Disease: ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
188 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2015 2015
AIDS, PROGRESSION TO
CUI: C1836233
Disease: AIDS, PROGRESSION TO
188 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2015 2015
Blood basophil count (lab test)
CUI: C0200641
Disease: Blood basophil count (lab test)
452 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2016 2016
Eosinophil count procedure
CUI: C0200638
Disease: Eosinophil count procedure
1133 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2016 2016
Granulocyte count
CUI: C0857490
Disease: Granulocyte count
150 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2016 2016
HIV-1, RESISTANCE TO
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
188 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2015 2015
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
CUI: C1836230
Disease: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
188 0.763 0.360 1 159204893 5 prime UTR variant T/C snv 0.25 0.700 1.000 1 2015 2015